These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 37378551)
21. The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis. Aldinger JP; Dobyns T; Lam K; Han JK Expert Opin Biol Ther; 2021 Sep; 21(9):1143-1149. PubMed ID: 34334061 [No Abstract] [Full Text] [Related]
22. Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference? Al-Ahmad M; Ali A; Khalaf M; Alterki A; Rodriguez-Bouza T BMC Pulm Med; 2023 Jul; 23(1):266. PubMed ID: 37464395 [TBL] [Abstract][Full Text] [Related]
24. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps. Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622 [TBL] [Abstract][Full Text] [Related]
25. The Effect of the Premedication with Systemic Corticosteroids and Antibiotics on Inflammation and Intraoperative Bleeding During Sinonasal Endoscopic Surgery for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Chrysouli K; Kyrodimos E; Papanikolaou V J Craniofac Surg; 2022 Jun; 33(4):e405-e408. PubMed ID: 35093993 [TBL] [Abstract][Full Text] [Related]
26. Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP). Garvey E; Naimi B; Duffy A; Hannikainen P; Kahn C; Farquhar D; Rosen M; Rabinowitz M; Toskala E; Nyquist G Int Forum Allergy Rhinol; 2024 Mar; 14(3):651-659. PubMed ID: 37506043 [TBL] [Abstract][Full Text] [Related]
27. Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis. Peters AT; Wagenmann M; Bernstein JA; Khan AH; Nash S; Jacob-Nara JA; Siddiqui S; Rowe PJ; Deniz Y Allergy Asthma Proc; 2023 Jul; 44(4):265-274. PubMed ID: 37480206 [No Abstract] [Full Text] [Related]
28. Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52. Bachert C; Khan AH; Lee SE; Hopkins C; Peters AT; Fokkens W; Praestgaard A; Radwan A; Nash S; Jacob-Nara JA; Deniz Y; Rowe PJ Int Forum Allergy Rhinol; 2024 Mar; 14(3):668-678. PubMed ID: 37548085 [TBL] [Abstract][Full Text] [Related]
29. Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis. Boyle JV; Lam K; Han JK Immunotherapy; 2020 Feb; 12(2):111-121. PubMed ID: 32075470 [TBL] [Abstract][Full Text] [Related]
30. A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation. Trimarchi M; Vinciguerra A; Rampi A; Tanzini U; Nonis A; Yacoub MR; Bussi M Acta Otorhinolaryngol Ital; 2022 Dec; 42(6):538-544. PubMed ID: 36654520 [TBL] [Abstract][Full Text] [Related]
31. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review. Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083 [TBL] [Abstract][Full Text] [Related]
32. Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status. Fujieda S; Matsune S; Takeno S; Ohta N; Asako M; Bachert C; Inoue T; Takahashi Y; Fujita H; Deniz Y; Rowe P; Ortiz B; Li Y; Mannent LP Allergy; 2022 Jan; 77(1):186-196. PubMed ID: 33993501 [TBL] [Abstract][Full Text] [Related]
33. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps. Patel GB; Peters AT Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132 [TBL] [Abstract][Full Text] [Related]
34. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Bachert C; Zinreich SJ; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Amin N; Joish VN; Fan C; Zhang D; Staudinger H; Pirozzi G; Graham NMH; Khan A; Mannent LP Rhinology; 2020 Feb; 58(1):10-17. PubMed ID: 31671432 [TBL] [Abstract][Full Text] [Related]
35. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai). Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094 [TBL] [Abstract][Full Text] [Related]
36. Dupilumab improves sleep quality in chronic rhinosinusitis with nasal polyps. Riva G; Garetto M; Borgione M; Piazza F; Prizio C; Dellea D; Albera A; Canale A; Pecorari G Am J Otolaryngol; 2024; 45(4):104310. PubMed ID: 38677148 [TBL] [Abstract][Full Text] [Related]